Finance News – Sanofi
What is your interest today?
Bitcoin
Crypto
Btc
Shares
Stocks
Investors
Tariffs
Stock
Ceo
Stock Market
Crypto Assets
Ethereum
Price
Cryptocurrency
Markets
Eth
Xrp
Etf
Ipo
Earnings
Bse
Stablecoin
Investment
Solana
Blockchain
Revenue
Inflation
Federal Reserve
Index
Sec
Trade
Interest Rates
Wall Street
Token
Treasury
Sensex
Coinbase
Nasdaq
Traders
Profit
Nse
Nifty
Sp 500
China
Investor
Bse Sensex
Gold
Nvidia
Monetary Policy
Economy
Financial Year
Market Analysts
Price Dip
Fastenal
Goldmine
Fidelity Wise Origin Bitcoin Fund
Kirkland
Rrif Withdrawal
Volatility Index
Pennsylvania Bill
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jun 09, 2025
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →
Investopedia • Jun 02, 2025
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
The agreement for a multibillion-dollar acquisition by Sanofi has led to a notable increase in the market value of Blueprint Medicines shares.
Read Full Article →
Investopedia • May 22, 2025
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
The company's market value increased significantly after the announcement of its upcoming purchase by a major pharmaceutical firm, highlighting investor confidence in the potential...
Read Full Article →